[Pathophysiologic basis for prevention and pharmacotherapy of benign cold thyroid nodules].
Brauer
V F H
VF
Medizinische Klinik III, Universität Leipzig.
Paschke
R
R
D000328:Adult; D000367:Age Factors; D000368:Aged; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007455:Iodine / Q000009:adverse effects / Q000172:deficiency / Q000378:metabolism / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009154:Mutation; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D012737:Sex Factors; D016606:Thyroid Nodule / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000235:genetics / Q000503:physiopathology / Q000517:prevention & control; D013972:Thyrotropin / Q000037:antagonists & inhibitors / Q000502:physiology; D013974:Thyroxine / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D013972:Thyrotropin; D007455:Iodine; D013974:Thyroxine